GlobeNewswire by notified

Evli Plc’s Interim Report 1–9/2023




Highlights for the period

  • Net revenue and operating profit increased due to good fund performance and the acquisition of EAB Group Plc in the autumn of 2022.
  • Demand for traditional investment funds increased – Evli attracted the second most fund subscriptions in Finland.
  • Recurring revenue’s share of turnover increased further, improving the quality of the result.

Financial performance January-September 2023 (comparison period 1-9/2022*)

  • Net revenue was EUR 78.0 million (EUR 66.7 million).
  • Operating profit was EUR 29.3 million (EUR 25.8 million).
  • Operating result of the Wealth Management and Investor Clients segment increased to EUR 26.3 million (EUR 22.3 million).
  • Operating result of the Advisory and Corporate Clients segment decreased to EUR 1.5 million (EUR 2.8 million).
  • At the end of September, assets under management amounted to EUR 17.1 billion (EUR 14.4 billion) on a net basis.
  • Return on equity was 22.8 percent (27.3%).
  • Earnings per share, fully diluted, was EUR 0.80 (EUR 0.71).
  • The ratio of recurring revenues to operational costs was 133 percent (127%).

* Includes carve-out figures for 1-3/2022.

Financial performance July-September 2023 (comparison period 7-9/2022)

  • The Group's net revenue was EUR 25.9 million (EUR 20.5 million).
  • The Group's operating profit was EUR 10.2 million (EUR 7.8 million).
  • Diluted earnings per share amounted to EUR 0.28 (EUR 0.21).


Uncertain sentiment in investment markets has persisted due to heightened interest rate and inflation fears, increased geopolitical risks and market volatility.

As a result of the acquisitions made during 2022, Evli has managed to strengthen its position in the market. With synergies from the acquisitions and non-recurring costs allocated to 2022, we estimate that the operating result will be well above the comparison period's level (EUR 30.9 million in 2022).


Income statement key figures
Net revenue, M€25.920.578.066.7
Operating profit/loss, M€10.27.829.325.8
Operating profit margin, %39.438.037.638.7
Profit/loss excl. non-recurring items related to mergers and acquisitions, M€27.3
Profit/loss for the financial year, M€8.26.723.520.7
Profitability key figures
Return on equity (ROE), %--22.827.3
Return on assets (ROA), %--8.48.0
Balance sheet key figures
Equity-to-assets ratio, %--34.231.3
Key figures per share
Earnings per Share (EPS), fully diluted, €
Dividend per share, €--1.15**1.06
Equity per share, €--4.824.04
Share price at the end of the period, €--19.316.30
Personnel figures
Number of permanent employees--310252
Number of temporary employees--4644
Share of personnel worked in Finland, %--9692
Other key figures
Expense ratio (operating costs to net revenue)0.610.630.630.62
Recurring revenue ratio, %***--133127
Market value, M€-511.2389.4

* Includes carve-out figures for 1-3/2022.
** Dividend approved by the General Meeting. The dividend was paid on March 23, 2023.
*** The calculation formula has been changed, which has resulted in an update of the previously reported benchmark figure. In the future, discretionary bonus payments will also be included as part of the operating costs.


In the third quarter of this year, the US economy continued to grow briskly, and Europe, too, avoided a recession, as a result of which prevailing market expectations of the end of the interest rate hike cycle vanished. Even though consumer prices have come down from last year's peaks, price increases were still above the central banks' long-term target of approximately two percent, thus restricting the central banks' freedom of maneuver. The strong momentum of the US economy came as a surprise, given the recent challenges faced by companies and consumers, such as high interest rates and consumer prices, difficulties of regional banks, weak housing and property markets, and the US domestic policy conflicts, as well as the many challenges of the global economy, including the increased polarization between the superpowers, growing protectionism, and an increase in export restrictions on high-technology goods.

Stock prices dropped in the third quarter in many places. The sluggish performance of equities and government bonds was due to investors' U-turn on interest rate expectations in late summer, in particular on hopes for a quick end to monetary policy tightening. High raw material prices, especially the price of crude oil, as well as declining corporate earnings also added to investors' caution. Higher-rated Investment Grade bonds as well as lower-rated High Yield bonds, however, performed strongly, which indicates that recession risks will remain at a low level.

The uncertainty of the operating environment and the uneven development of international markets, together with increased costs, were reflected in the development and result of Evli's business areas. Net revenue increased due to the merger with EAB Group Plc completed last year and the continued strong growth in commission income from alternative investment products and incentive business.

In the third quarter, the Group's net revenue increased by 26 percent from the comparison period and was EUR 25.9 million (EUR 20.5 million). Operating profit, in turn, increased by 31 percent to EUR 10.2 million (EUR 7.8 million). Commission income from traditional funds increased, being 12 percent higher throughout the early part of the year than in the previous year. By contrast, commission income from the Corporate Finance unit and brokerage activities remained lower during the quarter than in the previous year because of the slowdown in M&A activity and lower trading volumes.

In January–September, Evli's return on equity was 22.8 percent (27.3%). The ratio of recurring revenue to operational costs was 133 percent (127%). The Group's solvency and liquidity were at an excellent level.

Net revenue in the Wealth Management and Investor Clients segment increased by 30 percent in the third quarter to EUR 21.2 million (EUR 16.3 million). Client assets under management rose to EUR 17.1 billion (EUR 14.4 billion), driven by positive market developments and net subscriptions. Evli Fund Management Company's mutual fund capital, including alternative investment products, was approximately EUR 12 billion (EUR 10.1 billion). Net subscriptions of investment funds amounted to approximately EUR 235 million during the quarter, mainly from short-term fixed income funds as well as from domestic and global equity funds.

Net revenue in the Advisory and Corporate Clients segment decreased by 30 percent in the third quarter to EUR 2.5 million (EUR 3.6 million). The decrease was impacted by the decrease in advisory fees from M&A transactions. The unit's mandate base is reasonable, but tighter access to funding has made project completion more uncertain than before. Income from the Incentive business increased to EUR 2.2 million (EUR 2.0 million). In line with its strategy, the company has succeeded in winning new clients from both Swedish listed companies and domestic unlisted companies, and as a whole, the outlook for the company is good.

As in the early part of the year, the key drivers of Evli's strategy, international sales, and alternative investment products, developed twofold during the quarter. Net redemptions by international clients amounted to EUR 15 million. International clients accounted for 19 percent (21%) of Evli's total fund capital, including alternative investment products. Sales of alternative investment products totaled EUR 19 million (EUR 111 million) in the third quarter.

In the third quarter, Evli signed the investor statement on the European Sustainability Reporting Standards (ESRS). Evli continued its joint research project together with UNICEF Finland to explore how investors can promote child rights. In addition, Evli submitted its interim targets to Net Zero Asset Managers initiative and joined the global Nature Action 100 investor engagement initiative.


Additional information:
Maunu Lehtimäki, CEO, Evli Plc, tel. +358 (0)50 553 3000,
Juho Mikola, CFO, Evli Plc, tel. +358 (0)40 717 8888,

Evli Plc

We see wealth as an engine to drive sustainable progress. We draw on our heritage, broad expertise, and Nordic values to grow and manage wealth for institutions, corporations and private persons in a responsible way.

We are the best fund house in the Nordics1 and the leading asset manager in Finland2 offering a broad range of services including mutual funds, asset management and capital markets services, alternative investment products, equity research, share plan design and administration as well as Corporate Finance services. Responsible investing is integrated in every investment decision and our expertise is widely acknowledged by our clients. Evli has Finland's best expertise in responsible investment3.

Evli Group employs around 300 professionals and Evli has approximately EUR 17.1 billion in client assets under management (net 9/2023). Evli Plc’s B shares are listed on Nasdaq Helsinki Ltd.

1 Lipper Fund Awards 2023.
2 Morningstar Awards 2023 (c). Morningstar, Inc. All Rights Reserved. Awarded to Evli for the Best Fund House in Finland. Kantar Prospera External Asset Management Finland 2015, 2016, 2017, 2018, 2019, 2021, 2022, 2023. Kantar Prospera Private Banking 2019, 2020 Finland.
3 SFR Scandinavian Financial Research Institutional Investment Services Finland 2021, 2022.Kantar Prospera External Asset Management Finland 2023.

Distribution: Nasdaq Helsinki, main media,


To view this piece of content from, please give your consent at the top of this page.
To view this piece of content from, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Correction: Announcement of drawings (CK95) - Nykredit Realkredit A/S28.11.2023 15:01:23 CET | Press release

To Nasdaq Copenhagen Announcement of drawings (CK95) Pursuant to s 24 Danish Capital Markets Act, Nykredit Realkredit A/S hereby publishes drawings data as at 24 November 2023. Furthermore, the data will be distributed in the usual way through Nasdaq Copenhagen. Data on Nykredit and Totalkredit bonds is also available by ISIN code in Excel format on For further information about data format and contents, please refer to the Nasdaq website. Questions may be addressed to Morten Bækmand Nielsen, Head of Investor Relations, tel +45 44 55 15 21. Yours sincerely Nykredit Realkredit A/S Attachments Announcement of drawings Nykredit Realkredit A_S - 28-11-2023kfdata

Korrektion: Udtrækningsmeddelelse (CK95) - Nykredit Realkredit A/S28.11.2023 15:01:23 CET | pressemeddelelse

Til Nasdaq Copenhagen Udtrækningsmeddelelse (CK95) I medfør af kapitalmarkedsloven § 24 offentliggør Nykredit Realkredit A/S hermed meddelelse om udtrækninger pr. den 24. november 2023. Oplysningerne vil endvidere på sædvanlig måde blive formidlet via Nasdaq Copenhagen. Oplysningerne findes også i excel-format i Nykredits obligationsdatabase på For yderligere informationer om dataformat og indhold henvises til Nasdaqs hjemmeside. Spørgsmål kan rettes til head of investor relations Morten Bækmand Nielsen på tlf. 44 55 15 21. Med venlig hilsen Nykredit Realkredit A/S Vedhæftede filer Udtrækningsmeddelelse Nykredit Realkredit A_S - 28-11-2023kfdata

Philips launches ultra lightweight and flexible MR Smart Fit coils to improve radiology productivity and diagnostic confidence at #RSNA2328.11.2023 15:00:00 CET | Press release

November 28, 2023 Amsterdam, the Netherlands and Chicago, USA – RoyalPhilips (NYSE: PHG; AEX: PHIA), a global leader in health technology, today launched three new fit for purpose MR Smart Fit coils at #RSNA23. RF coils are an essential part of every MRI scan. The new ultra-light weight coils provide exceptional flexibility, significant reduction in patient setup time and optimization with Philips’ SmartSpeed AI solution, which allows for better image quality resolution and improved diagnostic confidence for healthcare providers. “Our new Smart Fit coils are an integral part of our patient-centric workflows in MR, with a focus on raising productivity and simplifying workflow,” said Ruud Zwerink, General Manager Magnetic Resonance at Philips. “They combine with our advanced AI-powered software that reduces scanning time and dramatically cuts the number of steps needed to complete an exam. These newly designed coils will help to speed up MR exam process, improving both efficiency and the

Ledende medarbejders transaktioner28.11.2023 14:58:15 CET | pressemeddelelse

Selskabsmeddelelse Nr. 7/2023 København, 28. november 2023 Ledende medarbejders transaktioner Bestyrelsen i Conferize A/S er i dag blevet bekendt med, at 7 investorer har købt 40,26 pct. af selskabets eksisterende aktier fra selskabets 2 hovedaktionærer til en samlet pris på ca. 0,8 mio. kr. – svarende til en pris på 0,01 kr. pr. aktie. Direktør Nicolai Bille Krogh har solgt aktier i Conferize A/S. NAVN:7DREAMS ApSÅRSAG:Nærtstående til Nicolai Bille Krogh, DirektørUDSTEDER:Conferize A/SFONDSKODE:DK0060816148BETEGNELSE:AktierTRANSAKTION:SalgHANDELSDATO:28.11.2023MARKED:Nasdaq First North Growth MarketANTAL STK:40.078.446SALGSSUM DKK:400.784,46 Herudover har Rothausen Development 2016 ApS ejet og kontrolleret af direktør i Suubz ApS, datterselskab i Conferize A/S, solgt aktier i Conferize A/S NAVN:Rothausen Development 2016 ApSÅRSAG:Nærtstående til Claus Andersen, Direktør i datterselskab Suubz ApSUDSTEDER:Conferize A/SFONDSKODE:DK0060816148BETEGNELSE:AktierTRANSAKTION:SalgHANDELSDATO:28

2024 Financial Calendar28.11.2023 14:56:32 CET | Press release

28 November 2023 News Release Pharma Equity Group 2024 Financial Calendar ​March 4Deadline for shareholder proposals - Annual General meeting​ ​March 20 ​Annual Report 2023​ April 16Annual General Meeting​ May 16Interim Report – for the three-month period ended March 31, 2024​ August 16Interim Report – for the six-month period ended June 30, 2024​ November 15Interim Report – for the nine-month period ended September 30, 2024 ​ Contact person – Investor Relations On the Company’s website further information and all published announcements can be found. Inquiries regarding relations with investors and the stock market can be directed to: Thomas Kaas Selsø, CEO, Phone: +45 4022 2114 E-mail: About Pharma Equity Group A/S Pharma Equity Group, a listed company on the Nasdaq Copenhagen stock exchange, is fully dedicated to advancing the medical projects of its subsidiary, Reponex Pharmaceuticals A/S. With an unwavering focus on healthc